Similarly, in a study by Fröhlich et al., patients with advanced cancer showed reduced left ventricular mass, associated increased plasma GH levels, and a reduced IGF-I/GH ratio, indicating increasing acquired resistance to GH, especially in patients with cachexia syndrome [37]. Here, GH1 is linked to cancer.